Pro Share Advisors LLC Esperion Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 35,706 shares of ESPR stock, worth $74,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,706
Holding current value
$74,982
% of portfolio
0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1.61 - $2.73 $57,486 - $97,477
35,706 New
35,706 $58,000
Q1 2023

May 11, 2023
SELL
$1.46 - $7.3 $2,327 - $11,636
-1,594 Reduced 10.23%
13,989 $22,000
Q4 2022

Feb 02, 2023
BUY
$5.09 - $8.5 $13,452 - $22,465
2,643 Added 20.43%
15,583 $97,000
Q3 2022

Nov 04, 2022
BUY
$5.45 - $8.13 $5,166 - $7,707
948 Added 7.91%
12,940 $88,000
Q2 2022

Aug 01, 2022
SELL
$4.77 - $6.67 $25,471 - $35,617
-5,340 Reduced 30.81%
11,992 $76,000
Q1 2022

May 10, 2022
BUY
$3.34 - $5.56 $24,438 - $40,682
7,317 Added 73.06%
17,332 $81,000
Q4 2021

Feb 08, 2022
BUY
$4.81 - $11.92 $48,172 - $119,378
10,015 New
10,015 $50,000
Q3 2021

Nov 12, 2021
SELL
$11.34 - $21.37 $134,662 - $253,768
-11,875 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$19.4 - $28.71 $21,184 - $31,351
1,092 Added 10.13%
11,875 $251,000
Q1 2021

May 14, 2021
BUY
$25.12 - $36.89 $18,789 - $27,593
748 Added 7.45%
10,783 $302,000
Q4 2020

Feb 09, 2021
BUY
$24.2 - $35.76 $57,596 - $85,108
2,380 Added 31.09%
10,035 $261,000
Q3 2020

Nov 13, 2020
SELL
$31.18 - $52.71 $8,636 - $14,600
-277 Reduced 3.49%
7,655 $285,000
Q2 2020

Aug 03, 2020
BUY
$30.04 - $51.31 $238,277 - $406,990
7,932 New
7,932 $407,000
Q1 2020

May 15, 2020
SELL
$27.44 - $73.84 $256,317 - $689,739
-9,341 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$35.4 - $59.82 $30,196 - $51,026
-853 Reduced 8.37%
9,341 $557,000
Q3 2019

Nov 12, 2019
SELL
$34.47 - $47.53 $2,929 - $4,040
-85 Reduced 0.83%
10,194 $374,000
Q2 2019

Aug 13, 2019
SELL
$40.1 - $52.33 $52,972 - $69,127
-1,321 Reduced 11.39%
10,279 $478,000
Q1 2019

May 15, 2019
BUY
$40.11 - $53.57 $4,091 - $5,464
102 Added 0.89%
11,600 $466,000
Q4 2018

Feb 14, 2019
SELL
$36.99 - $59.11 $82,561 - $131,933
-2,232 Reduced 16.26%
11,498 $529,000
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $22,040 - $27,812
-541 Reduced 3.79%
13,730 $609,000
Q2 2018

Aug 13, 2018
SELL
$36.2 - $76.4 $6,950 - $14,668
-192 Reduced 1.33%
14,271 $559,000
Q1 2018

May 14, 2018
SELL
$65.94 - $80.76 $142,957 - $175,087
-2,168 Reduced 13.04%
14,463 $1.05 Million
Q4 2017

Feb 14, 2018
BUY
$43.47 - $67.43 $43,078 - $66,823
991 Added 6.34%
16,631 $1.1 Million
Q3 2017

Nov 13, 2017
BUY
$43.8 - $52.77 $119,486 - $143,956
2,728 Added 21.13%
15,640 $784,000
Q2 2017

Aug 11, 2017
BUY
N/A
12,912
12,912 $598,000

Others Institutions Holding ESPR

# of Institutions
209
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $140M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email